(PRLEAP.COM) LaserHairRemovalOrlando.Com has just added Florida Vein Care and Cosmetic Center in Lake Mary, Florida to their rapidly growing site. Patients throughout the Lake Mary and greater Orlando area will now be able to visit LaserHairRemovalOrlando.Com in order to find information concerning this participating clinic.

Laser hair removal is an alternative to electrolysis, plucking, waxing, shaving and creams. While all of these methods are effective at removing hair, some are painful and time consuming. Laser hair removal is quick and virtually painless. A lip and chin can be treated in 1 minute and bikini lines treated in less than 5 minutes. Clients can also apply a numbing cream 1-2 hours before treatment to minimize any discomfort.

Florida Vein Care & Cosmetic Center also treats varicose and spider veins. Nothing gives you more confidence than knowing you look your best. Since 1998, Florida Vein Care and Cosmetic Center has helped thousands of men and women feel better about their appearance by providing the finest in treatments, service, and technology. Whether you suffer from acne or varicose veins, or would just like to turn back the hands of time, Florida Vein Care and Cosmetic Center offers a variety of options to make you look and feel great. From vein care to skin care, cosmetic procedures to dermatology, they’re committed to providing you with excellence in communication, comfort, and service.

Eliminate varicose and spider veins painlessly and effectively at Florida Vein Care’s Lake Mary or Metro West office. Richard S. Bragg, M.D., the Board Certified Vein Specialist and Medical Director of Florida Vein Care and Cosmetic Center, has performed thousands of vein and cosmetic procedures and offers the most advanced vein care treatments available, including: Endovenous Laser for varicose veins, Infection Sclerotherapy for spider veins, Ultrasound Guided Sclerotherapy, Microsurgery for varicose veins, and Laser Treatment for facial veins, moles, cherry spots and brown spots.

About Florida Vein Care and Cosmetic Center
Directed by board-certified vein specialist Richard S. Bragg, M.D., Florida Vein Care and Cosmetic Center combines state-of-the-art equipment with the latest surgical and non-surgical techniques. Dr. Bragg’s interest in aesthetic medicine began in medical school when his wife became troubled over tiny spider veins on her legs. As he researched ways to treat her condition, his passion for making people feel better about their appearance grew. Today, thanks to numerous referrals and “word-of-mouth” advertising, Florida Vein Care & Cosmetic Center has become one of Central Florida’s preferred providers, offering the most advanced and effective vein and cosmetic treatments available.

At Florida Vein Care and Cosmetic Center, we’re committed to providing the highest level of care by offering the safest, most advanced, and effective treatments available. We believe that the human mind and spirit are equal to the human body; and we are dedicated to enhancing your life through excellence in communication, comfort, and service. For additional information call (407) 841-8800 or go online to, http://www.laserhairremovalorlando.com/press_releases.htm

Contact:
Florida Vein Care and Cosmetic Center
(407) 841-8800
http://www.laserhairremovalorlando.com

The days of lengthy incisions, stitches and scars to treat varicose veins are gone at The Nebraska Medical Center in Omaha. Now, a laser fiber and skilled vascular surgeon Jason Johanning, M.D. can fix the problem with little discomfort, tiny incisions and believe it or not — no stitches.

“It’s amazing…I feel great!” said Rich Kubat, 67, a pharmacist who says standing on his feet for 40 years took a toll on his legs. “The veins were popping out. People were commenting and I had a constant aching in my legs to the point that I couldn’t wait to get home and get my feet up,” Kubat recalled.

Those complaints are common among people with varicose veins, which are often caused by a faulty valve in the veins that run just under the skin.

“When those veins become enlarged and dilate abnormally — it creates the varicose veins,” explained Dr. Johanning. “The ultimate problem, however, is a bad valve somewhere within the vein system.”

Dr. Johanning finds and treats the problem using ultrasound, a laser fiber and incisions about the size of small freckle. “Essentially what we do is put a laser fiber into the large superficial vein to scar it down. Then we remove enlarged adjacent veins through incisions so small the skin heals on its own,” said Dr. Johanning.

“The recovery time was really very short,” said Kubat. “I took a pain pill the first night and after that it was just an aspirin or Motrin. So the pain was almost non-existent.”

Julie Karloff, 42, a nurse of 20 years, came to Dr. Johanning because her legs were tired, throbbing and aching. For Julie the issue was more medical than cosmetic. “After my third child, I got back into a more active lifestyle. I noticed that when I was exercising or working my legs were becoming more and more tired and more uncomfortable.”

Dr. Johanning says women get varicose veins more often than men because of their physiology. Julie had the surgery done last year and says she would “absolutely do it again.”

Luminetx Corporation, a leading developer and marketer of bioscience technologies, including its patented infrared vein imaging system, VeinViewer(tm), announced today a 3-year distribution agreement with Diomed Holdings, Inc. (AMEX:DIO), an industry leader in the area of minimally invasive medical technologies, including its patented EVLT(r) for varicose veins.

The agreement, which provides exclusive distribution rights to the schlerotherapy, phlebectomy and varicose vein treatment markets in the United States and United Kingdom and includes both a $1 million investment in Luminetx and a grant of 600,000 Diomed warrants, is expected to generate a minimum of $16 million in Luminetx revenues over the term of the agreement.

“We looked at several companies working in the schlerotherapy and phlebectomy arenas, and chose Diomed as our distribution partner because we believe they have the winning technology,” said Jim Phillips, CEO of Luminetx. “We were also very impressed with the caliber of the management team at Diomed.”

Hailed by Time magazine as “one of the most amazing medical inventions of the year,” VeinViewer is a breakthrough device that will revolutionize medical procedures and improve the quality of global health care. The visionary product is a venous imaging system that uses infrared light and other patented technologies to project a real-time image of subcutaneous veins directly onto the surface of a patient’s skin.

“We believe that the Luminetx VeinViewer is an important adjunct to our core EVLT business and will enhance our competitive advantage in the treatment of venous disease,” said James A. Wylie, president and CEO of Diomed Holdings, Inc. “Additionally, as vein treatment continues its move from the hospital to outpatients facilities and physician offices, we expect to leverage our existing sales and marketing organization by offering physicians an array of medical tools for the treatment of superficial venous disorders, from reflux of the GSV to unsightly spider veins.”

VeinViewer, which was cleared by the FDA in 2004, is undergoing key clinical evaluations in physician offices in both the U.S. and South America. Steven E. Zimmet, MD, FACPh, is the President of the American College of Phlebology. “The first time I saw the VeinViewer in action I was astounded by what I saw,” he says. “It is clear to me that the VeinViewer will be a very useful tool in my everyday phlebology practice.”

Roberto Kasuo Miyake, MD, PhD, is a noted international researcher and expert schlerotherapist and vascular surgeon at the Clinica Miyake in Sao Paulo, Brazil. He is a frequent presenter at international medical conferences and was inducted as a Fellow in the American Society for Laser Medicine and Surgery this year. “VeinViewer has been a key component of our treatment protocols, and has radically improved our patient outcomes,” Miyake said. “With VeinViewer, the marks are exact, which eliminates the need for ‘fishing,’ reduces additional trauma to the area and actually allows patients to heal faster.”

Steve Elias, MD, director of the Center for Vein Disease at Englewood Hospital and Medical Center adds, “VeinViewer not only allows physicians better visibility of veins targeted for treatment, but also provides verification of full and complete treatment. VeinViewer fulfills a basic surgical principle — if I can see it, I can do it.” Elias is also an assistant professor of surgery at Mt. Sinai School of Medicine in New York City and a Fellow in the American College of Surgeons.

Phillips notes that Luminetx is attracting the interest of key thought leaders in phlebology, schlerotherapy, dermatology, phlebotomy, pediatric venapuncture (i.e., blood collection, IV-PICC line insertions), interventional radiology, plastic surgery and a number of segments where venous access is critical to patient comfort and practitioner success.

“We’re seeing an enormous variety of applications and opportunities for VeinViewer technology among large physician practices,” Phillips says. “We believe that this pivotal partnership will be the industry genesis of a bright future for VeinViewer, as well as for the patients and physicians who will benefit from this innovative imaging technology. We are in discussions with numerous health care manufacturers, distributors and providers worldwide for other applications of VeinViewer breakthrough technology.”

Diomed plans to display the VeinViewer at several upcoming medical meetings this fall, including the American College of Surgeons Annual Clinical Congress in San Francisco (Oct. 16-20), the 19th Annual Congress of the American College of Phlebology meeting also in San Francisco (Nov. 10-13) and the VEITH Symposium in New York City (Nov. 17-20).

The VeinViewer is expected to be available for general distribution in the first quarter of 2006. Additional information about VeinViewer can be found at www.Luminetx.com and www.DiomedInc.com

Ingredients
Horse Chestnut 3x, 6x, 3c, Witch Hazel 1x, 4x, 3c, Honeybee 3x, 6x, 12x, 30x, Wind Flower 3x, 6x, 30x, St.Mary’s Thistle 3x, 6x, Club Moss 6x, 30x, Vegetable Charcoal 6x, 30x, Ergot 3x. Aloe Vera, Horse Chestnut Seed Extract at 20% Escin, Butcher’s Broom at 9-11% ruscogenin, Grape Seed Extract at 95% proanthocyidins, Gotu Kola Extract at 8-10% triterpenoids, Vitamin C, Vitamin E, Vitamin A, Rutin, Neem Oil, Tea Tree Oil, Quercetin, Bromelain, Lecithin, Ginger, and Cayenne.

LAS VEGAS — Nu Image MedSpa Inc. today announced that it proudly adds SkinMedica products to its arsenal, which includes TNS Recovery Complex(R), the only facial skin care product with Nouricel MD to help reduce the visible signs of aging, EpiQuin Micro(TM), a 4% hydroquinone for the treatment of Melasma and postinflammatory hyperpigmentation and VANIQA(R), the first and only prescription product for women clinically proven to slow unwanted facial hair (UFH) growth in women.

SkinMedica of Carlsbad, Calif., is a privately held specialty pharmaceutical company focused on dermatology that markets both prescription products and cosmeceuticals (skincare products dispensed by a physician). Their full line of cosmeceutical products, that are sold only through physicians, include TNS Recovery Complex, designed to help improve the health and appearance of aging skin. In July of 2003 SkinMedica launched its first pharmaceutical product, EpiQuin Micro(TM) (Hydroquinone USP 4%) for the treatment of Melasma and postinflammatory hyperpigmentation. In July 2004, they acquired all U.S. rights and certain international rights to VANIQA(R) (eflornithine hydrochloride) Cream, 13.9%. VANIQA is the only prescription pharmaceutical product approved by the U.S. Food and Drug Administration (FDA) to slow the growth of unwanted facial hair in women. For more information, visit SkinMedica at http://www.skinmedica.com/main.php.

“Everyone knows ‘Perfect 10′ Bo Derek,” noted Chief Medical Officer Dr. Daniel McGrath. “But did you know Bo Derek uses SkinMedica’s products for maintaining her skin’s youthful luminescence? Below is an excerpt from SkinMedica’s 1/5/05 PR:”

Bo Derek, “The Perfect 10,” Undertakes Her First Skincare Endorsement, SkinMedica’s TNS Family of Products

No one better exemplifies “enduring beauty” than Bo Derek, and she advises that the first building block is maintaining skin health and beauty. At 48, Bo’s radiant beauty invites frequent inquiries as to her secret. How does she do it? For the first time, the “Perfect 10″ has decided to reveal her secret and endorse a product line that she believes is the best available — SkinMedica’s(R) Tissue Nutrient Solution (TNS) Recovery Complex(R) and family of products. Bo credits the TNS line for maintaining her skin’s youthful luminescence.

“You have to read the entire text to fully appreciate Bo Derek’s endorsement. It can be found at http://www.skinmedica.com/corporate/newsroom/press_release?id=37. From the Bo Dereks to the average Ms. Smiths of the world, we are stockpiling our arsenal to handle all types of customers. The inclusion of such effective products from premier companies like SkinMedica and our upcoming potential merger with InDigiNet, Inc. (OTC Bulletin Board: IDGC), we’re on a roll towards being the leader in the medspa industry,” concluded Dr. McGrath.

About Nu Image MedSpa Inc.

At Nu Image MedSpa, not only are our customers treated with the best that technology has to offer, they also get expert consultations from our skilled medical staff. Our trend-setting spa-like facilities, combined with our friendly staff, are all you need for the best skin care experience ever. Our facilities offer FDA-approved procedures like BOTOX(R), Restylane, Laser Hair Removal, IPL-Skin Rejuvenation, Microdermabrasion, Chemical Peels, Collagen and Leg Vein Treatment. We work only with the most advanced laser equipment to achieve your desired results. Our medical staff is one of our most valued assets and they are trained in a culture of warmth, friendliness and customer service. Everything at the MedSpa is designed with your comfort and convenience in mind, even our business hours which are flexible to adjust to your needs. Making you look good and feel good is what we are here for!

The Nu Image MedSpa franchise business development program allows the investor to easily participate in one of the fastest growing and most lucrative sectors of the healthcare industry. Nu Image is committed to continually setting the highest levels of excellence and innovation for our clients. Medical Spas are fast becoming the facility of choice among women and men seeking rejuvenating skin care procedures. For more information about Nu Image MedSpa visit http://www.nuimagemedspas.com.

There are several easy things you can do to help prevent varicose and spider veins and to relieve discomfort from the ones you have:

* Protect your skin from the sun by wearing sunscreen to limit spider veins on the face.

* Exercise regularly to improve your leg strength, circulation, and vein strength. Focus on exercises that work your legs, such as walking or running.

* Control your weight to avoid placing too much pressure on your legs.

* Do not cross your legs when sitting. However, try to elevate your legs when resting.

* Do not stand for long periods of time. If you have to stand for long periods of time, shift your weight from one leg to the other every few minutes. If you have to sit for long periods of time, stand up and move around or take a short walk approximately every 30 minutes.

* Wear elastic support stockings, but avoid clothing that is too tight or that will constrict your waist, groin, or legs.

* Make sure to include high-fiber foods in your diet since constipation can contribute to varicose veins. High fiber foods include fresh fruits and vegetables and whole grains, like bran. Control your salt-intake. Salt, or sodium, can cause you to retain water or swell.

Illustra Cosmetic Laser Treats Spider Veins Without Bruising;

Facilitates Fast Outpatient Treatment

Cynosure, Inc., a leading developer of medical lasers, introduced today the Illustra(TM), a compact diode-pumped solid state laser for removing facial telangiectasias, otherwise known as spider veins. The Illustra benefits both doctors and patients by offering a cost-efficient, effective way to remedy facial spider veins immediately, without purpura or bruising following the treatment. The Illustra has been cleared for market distribution by the U.S. Federal Government.

With the Illustra, results are immediate; there is no postoperative recovery time. Therefore, patients can now schedule laser treatments for a short time, such as a lunch hour, for times when they wish to be presentable without imperfection. For dermatologists and plastic surgeons, the laser is economical to own and operate, making it an ideal complement to the technological offering in today’s most advanced vascular treatment practice.

“Doctors are looking for an inexpensive, efficient vascular laser specifically to treat spider veins,” said Rob Levenson, vascular product manager of Cynosure. “The Illustra is the ideal choice for patients and practice. Patients are thrilled to see instant results with no side effects such as bruising. Doctors find it remarkably cost-efficient and easy to use.”

“We found that the addition of the 532 nm diode capability fit into our laser program immediately,” said Dr. Jennifer Lloyd. “The application appealed to a large group of patients, and they were pleased with the simplicity of the treatment and the results. The laser is well designed and easy to use, and it is important to our ability to provide total dermatological care.”

The Illustra is portable, uses standard electrical power, and requires no warm-up time. It has five pulsewidths–10, 20, 50, 100, and 200 milliseconds, and operates on continuous wave or pulsed mode with a spot size of .7mm. Optional handpieces are .3, .5, 1.0 and 1.4 mm. Contemporary design and convenience features make the Illustra easy and fast to use. The Illustra is currently priced at $50,000 and is now available.

Millions of people of age 40 and beyond suffer from facial spider veins. They are looking for a solution which is simple, effective, and painless. With the Illustra, Cynosure offers doctors an economical way to add a state-of-the-art laser to their vascular treatment options.

About Cynosure, Inc.

Cynosure develops, manufactures and markets laser technology for aesthetic treatment applications, including hair removal, leg veins, scar revision, port-wine birthmarks, facial spider veins, stretch marks, removal of tattoos and pigmented lesions. These products have given Cynosure worldwide recognition in the practices of dermatologists, plastic surgeons and vascular surgeons.

Brand and product references herein are registered trademarks or trademarks of their respective holders.

Advanced Medical Products Inc. of Las Vegas, today announced that a U.S. Patent (U.S. Patent No. 6,224,618) will be officially issued May 1, 2001, related to the company’s Arachnophlebectomy Surgical Device.

The Arachnophlebectomy Surgical Device is a sterilized, disposable needle with a fork-like design and a beveled vortex that is used by physicians to destroy spider veins.

According to Advanced Medical Products, the device uses a simple procedure called the Miglin Method(TM). Usually performed in a physician’s office with a local anesthetic administered to the area to be treated, the Arachnophlebectomy Surgical Device is inserted into the skin with the center of the needle’s fork-like head capturing the targeted vessel.

The needle is rotated (at least 360 degrees clockwise and counterclockwise), transecting the spider vein. The procedure is repeated every 1 to 2 centimeters along the spider vein causing the vein to blanch and allowing the body to resorb the destroyed tissue.

“The creation of this Arachnophlebectomy Surgical Device is extremely significant because its unique fork-like design and beveled vortex make the treatment very simple and minimally invasive,” said Cameron Stuart, president of Advanced Medical Products.

Clinical studies of the device and procedure have been conducted by teaching staff at Northwestern University in Chicago and the University of Nevada School of Medicine in Las Vegas. According to preliminary reports, the Arachnophlebectomy Surgical Device is safe and effective in destroying spider veins with minimal side effects.

The device was introduced to the medical community in March at the Annual Meeting of the American Academy of Dermatology in Washington, D.C.

For more information about the Arachnophlebectomy Surgical Device and clinical study information, visit www.miglinmethod.com or call 800/864-2792.

COPYRIGHT 2001 Business Wire

PARADISE VALLEY, Ariz., May 18 /PRNewswire/ — MW Medical, Inc. (OTC Bulletin Board: MWMD) announced that it has received IRB approval from Independent Review Consulting, Inc., San Anselmo, California to conduct a Phase II trial on the treatment of spider veins (telangiectasias) in the legs with the company’s microwave delivery system (MDS). The approval is based upon the results of pre-clinical studies, and a human clinical trial in Europe which demonstrated the ability of microwave energy to cause fading of spider veins at doses within the established safety range.

According to MW Medical Inc.’s Chief Scientist, Dr. Robert Spertell, microwaves work by generating heat that causes the small blood vessels making up spider veins to coagulate and eventually fade. The effectiveness is a result of the greater than two-fold absorption of microwave energy by blood as compared to skin.

“We are very excited about the potential for this new application of our microwave system,” said Mitch DeShon, VP Sales of MW Medical, Inc. The worldwide annual market for the treatment of spider veins is over $1 Billion, and thus far sclerotherapy still dominates the market. Mr. DeShon adds, “We are confident that MW Medical’s microwave technology can capture a significant portion of that market. In fact, it is our belief that microwave technology can significantly expand the existing market established by sclerotherapy.”

MW Medical recently filed a 510(K) application to the Food and Drug Administration for cosmetic hair removal. Future additional indications for the MDS platform include the use in the treatment of orbital facial wrinkles and stretch marks.

Statement Under the Private Securities Litigation Reform Act.

With the exception of the historical information contained in this release, the matters described herein contain forward-looking statements that involve risk and uncertainties that may individually or mutually impact the matters herein described, including but not limited to product acceptance, economic, competitive, governmental, results of litigation, technological and/or other factors, which are outside the control of the Company.

COPYRIGHT 1999 PR Newswire Association, Inc.

http://www.spidervein.info/
http://www.spidervein.info/news/news.html

http://www.spidervein.info/
http://www.spidervein.info/news/news.html

Q. I have spider veins on my legs. Is there anything I can do to get rid of them?

A. Approximately 35 percent of American women have telangiectatic (CQ) leg veins. Telangiectases, commonly known as “spider veins” or “broken vessels” are not just a cosmetic concern. They cause other problems in about half of the women who have them, including aching, itching, burning and throbbing.

The treatment for spider veins is called sclerotherapy. It includes a variety of solutions that can be injected into a damaged vein, resulting in the closing-off of that vessel. The origins of this approach date back to 1682, when a physician named Zollikofer injected acid into a vein to create a clot, thus introducing a crude type of sclerotherapy. In the United States these days, the most commonly used solution is strong salt water (hypertonic saline). These injections are somewhat painful, but have the important benefit of not causing serious allergic reactions. Side effects may include temporary bruising, a darkening along the path of the blood vessels and, rarely, a sore in the area of the injection.

Most women receive an improvement of from 60 percent to 80 percent in the appearance of the problem area with a series of one to four or more treatments, typically performed every six weeks. Most women are good candidates for treatment. And given the low risk of side effects and excellent cosmetic results, sclerotherapy is an option worth considering. While newer treatments have been developed to treat spider veins, including lasers, none has proven more effective than sclerotherapy.

—————-

Dr. Steven F. Wolfe is a Greensboro physician who specializes in dermatology. On Call, co-sponsored by the Greater Greensboro Society of Medicine, runs every other week in the Life section. It is a health education column and is not a substitute for medical advice from your doctor. If you have a health-related question, write to On Call, c/o Life Department, News & Record, P.O. Box 20848, Greensboro N.C. 27420. Questions cannot be answered personally.

COPYRIGHT 1997 News & Record